Alar Pharmaceuticals

6785.TWO

9.81 USD

0.14

+1.45%

Overview

Last close

9.81 usd

Market cap

655.21M usd

52 week high

9.81 usd

52 week low

3.40 usd

Target price

9.24 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

16420.111

Price/Book Value

8.4986

Enterprise Value

581.24M usd

EV/Revenue

14556.5483

EV/EBITDA

413.1064

Key financials

Revenue TTM

39929.89 usd

Gross Profit TTM

28776.29 usd

EBITDA TTM

-4.09M usd

Earnings per Share

-0.01 usd

Dividend

0.01 usd

Total assets

78.46M usd

Net debt

-20.81M usd

About

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. The company develops ALA-1000 for the treatment of opioid use disorder. Its pre-clinical stage product includes ALA-1300 and ALA-2000 for the treatment of opioid use disorder; ALA-4000 to treat Parkinson's disease; ALA-3000 for treating treatment-resistant depression; and ALA-5000 to treat schizophrenia. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.